Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis

Young Sil Yoon, Dongryeol Ryu, Min Woo Lee, Sungpyo Hong, Seung Hoi Koo

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)


During fasting periods, hepatic glucose production is enhanced by glucagon to provide fuels for other organs. This process is mediated via cAMP-dependent induction of the CREB regulated transcriptional coactivator (CRTC) 2, a critical transcriptional activator for hepatic gluconeogenesis. We have previously shown that CRTC2 activity is regulated by AMP activated protein kinase (AMPK) family members. Here we show that adiponectin and thiazolidinedione directly regulate AMPK to modulate CRTC2 activity in hepatocytes. Adiponectin or thiazolidinedione lowered glucose production from primary hepatocytes. Treatment of both reagents reduced gluconeogenic gene expression as well as cAMP-mediated induction of CRE reporter, suggesting that these reagents directly affect CREB/CRTC2- dependent transcription. Furthermore, adiponectin or thiazolidinedione mediated repression of CRE activity is largely blunted by co-expression of phosphorylation defective mutant CRTC2, underscoring the importance of serine 171 residue of this factor. Taken together, we propose that adiponectin and thiazolidinedione promote the modulation of AMPK-dependent CRTC2 activity to influence hepatic gluconeogenesis.

Original languageEnglish
Pages (from-to)577-583
Number of pages7
JournalExperimental and Molecular Medicine
Issue number8
Publication statusPublished - 2009 Aug 31
Externally publishedYes


  • AMP-activated protein kinases
  • Adiponectin
  • CRTC2 protein, human
  • Gluconeogenesis
  • Liver
  • Thiazolidinediones

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry


Dive into the research topics of 'Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis'. Together they form a unique fingerprint.

Cite this